Join Dr Olly Hulson, an experienced prostate cancer diagnostics lead and advocate for educational innovation, as he explores the vital role of MRI in the active surveillance pathway. This session focuses on the development, application, and real-world impact of the PRECISE criteria in guiding MRI monitoring for men undergoing active surveillance.
With a passion for patient-centred communication and informed decision-making, Dr Hulson shares his experience revising patient education materials and training colleagues in transperineal biopsy techniques. He also addresses the ongoing misconceptions around prostate biopsy and over-diagnosis, drawing on his work with Prostate Cancer UK’s Clinical Champions Programme.
Ideal for Imaging Specialists, Urologists, and Primary Care teams, this session provides a balanced view of the benefits and limitations of MRI in surveillance and equips participants with insights to enhance practice and patient confidence.
